Frontier Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,591
Closed -$1.52M 270
2023
Q2
$1.52M Buy
+6,591
New +$1.79M 0.01% 252
2020
Q4
Sell
-27,299
Closed -$3.24M 289
2020
Q3
$3.24M Sell
27,299
-44,615
-62% -$4.84M 0.03% 276
2020
Q2
$8.14M Sell
71,914
-20,998
-23% -$2.06M 0.07% 234
2020
Q1
$6.2M Buy
92,912
+38,712
+71% +$3.23M 0.07% 224
2019
Q4
$4.94M Buy
54,200
+32,718
+152% +$3.17M 0.04% 252
2019
Q3
$1.85M Sell
21,482
-5,993
-22% -$562K 0.01% 273
2019
Q2
$2.88M Sell
27,475
-60,228
-69% -$6.45M 0.02% 276
2019
Q1
$11M Buy
87,703
+3,835
+5% +$477K 0.08% 230
2018
Q4
$9.45M Buy
+83,868
New +$13M 0.08% 236

Other funds holding MDGL